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A point mutation (Ala-589 to Thr) in the transmembrane protein of the human immtmodeficlency vnus type 1 (HIV-I ) has been shown to decrease 
the sensitivity of the virus to the neutralizing effect of human HIV-1 specific antibodIes [( 1990) J Vlrol 64. 3240- 32481. Here 17-residue peptides 
with the parental and mutant sequences were compared. the parental peptide bound antibodies of sera from HIV-l infected persons more frequently 
and with higher affinity than the mutant peptide. However. according to cu-cular dlchrolsm (CD). NMR spectroscopy and molecular modelling 
the peptides habe inchstingulshable backbone conformations under a variety of experimental condltlons. These techmquea showed for both peptldes 
that no ordered hehx was present m water solution. However, for both pepttdes in alcohol-water solutions approximately 60% a-hehx coulu be 
induced. The three-dimenslonal structures of these pcptides provide a basis for understandmg how this mutation in the transmembrane protein 
may affect the interactlon with both the outer envelope glycoprotein and with antlbodies. 
Antigemc peptide: 3D structure: Escape mutant: Human Immunodeficlency virus type I 
1. INTRODUCTION 
A decrease in sensitivity to the neutralizing effect of 
antibodies to the human immunodeficiency virus type 
1 (HIV-l) in some human sera was previously found to 
be due to a mutation from alanine to threonine at posi- 
tion 589 in the viral transmembrane protein [l]. 
Garnier’s algorithm [3,3] predicts this region to be cx- 
helical, while the substitution to threonine lowers the 
probability of formation of an a-helix and increases the 
probability of formation of a p-structure. We investi- 
gated the antigenic and secondary-structural effects of 
the substitution on the synthetic peptide HIV-env 583% 
599 using nuclear magnetic resonance spectroscopy 
(NMR) and circular dichroism spectropolarimetry 
(CD). Interest in this peptide is further motivated by its 
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immunosuppressive effects in vitro [4,5] and its recently 
reported binding to a cell-surface molecule of T cells [6]. 
Both NMR and CD provide conformational infor- 
mation on peptides and small proteins. The NMR data 
provide specific internuclear distance restraints in solu- 
tion (i.e. 2D and 3D NOESY experiments). although 
the technique is limited to interproton distances that are 
less than 5 8, [7]. Structures of antigenic peptides in 
solution obtained using NMR have previously been re- 
ported [8,9]. Recently, a p-turn was demonstrated by 
NMR in a peptide with a sequence C-terminally contig- 
uous to the one studied here [lo]. 
In this paper we describe the antigenicity (reactivity 
with antibodies) of the HIV-env 583-599 peptide and its 
mutant (Ala-589 + Thr) counterpart. We applied 
NMR and CD, coupled with molecular modelling, to 
determine the structures of the two peptides under a 
variety of experimental conditions. 
2. EXPERIMENTAL 
2. I. .S_mtlrrric prpirtie.5 
The peptldes LQARILAVERYLKDQQL (HIV-env 583- 599, the 
parental peptide) [1 11. LQARILTVERYLKDQQL (the mutant pep- 
tide), and as a control m the competitlon experiments DRPEGIEE- 
EGGERDRDRS (HIV-en\ 735 752) [12] were prepared as previously 
described [1 I]. 
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2.2. Seru 3. RESULTS 
Sera from 42 persons confirmed by Western blottmg to have anti- 
bodies to HIV-l were used. Sixteen HIV-1 negative sera from blood 
donors served as controls. 
3.1. Immunochemicul 
2.3. Enzyme immune-assays 
Microtitre plates (Immunoplate Maxisorp, Nunc. Roskilde, Den- 
mark) were coated with peptide (10 &ml phosphate-buffered sahne 
with sodium merthiolate. PBS-M) or mock-coated with only PBS-M, 
blocked and washed as previously described [I I]. Human serum di- 
luted 1120, or titrated from 1120 to 112,500. was incubated on the 
plates; bound antibodies were detected by peroxidase labelled rabbit 
antibodies to human IgG y-chains (Dakopatts, Copenhagen, Den- 
mark), and absorbance measurement after color development, as de- 
scribed [I 11. The cut-off for positive reactivity m the titrations was an 
absorbance difference of 0.1. 
In the competition assay [13] sera were diluted beyond regions of 
absorbance plateaus (from 1120 to 112,500) and preincubated with 
6-60 pmol/dm3 peptide overnight at 4°C. The enzyme immunoassay 
was then carried out as described above. 
The antibody reactivity of the parental HIV-env 583- 
599 and mutant ‘589T’ peptides is shown in Fig. 1. 
Eleven out of 42 HIV-l-positive sera reacted strongly 
with the parental and, in all but one case, significantly 
less with the mutant peptide. The other 31 HIV-l-posi- 
tive sera, which reacted weakly with the parental pep- 
tide. had even weaker reactions with the mutant pep- 
tide. The 16 HIV-negative sera gave no significant reac- 
tions. The 11 HIV-l-positive sera that were strongly 
reactive with the parental peptide also gave higher reac- 
tivity titers with that peptide (average log(dilution fac- 
tor ? S.D.) = 2.3 + 0.5) than with the mutant peptide 
(1.0 +_ 0.3). 
To determine the coating efficiency, both peptides were radiola- 
belled with “‘1 by the lactoperoxidase method to activities of 0.55 
1.0 x 10’ cpm/pg. The iodinated peptide was incubated in immuno- 
plates overnight at 4°C. After five washes the wells were cut apart and 
their radioactivity measured in a gamma-counter. At the concentra- 
tion used for coating m the enzyme immunoassay, i.e. 10 &ml, 3% 
of 5833599 and 6% of the mutant peptide had bound. Comcubation 
with the same amount of the respective unlabelled peptide reduced the 
binding of both labelled peptides by 60%. We conclude that the unla- 
belled mutant peptide coated at least as efficiently as unlabelled 583- 
599. 
2.4. Circular dichroism 
All CD spectra were recorded at room temperature with a J-600 CD 
spectropolarimeter (Jasco. Tokyo, Japan) with cylindrical cells and 
pathlengths of 1 and 0.02 cm. Peptide solutions were prepared m HZ0 
over a range of pH values and m 40% trifluoroethanol (TFE) and 60% 
Hz0 near pH 3 at concentrations of 50-100~mol dm-‘. Experiments 
were repeated at least three times with varying concentrations. The 
CD spectra were fitted with the CONTIN fitting algorithm [14] to 
estimate the amount of secondary structure present Both peptides 
were found to have indistinguishable secondary structures and to be 
largely a-helical m the TFE/HzO mixture over the pH range of 2.5-9.0. 
In 100% Hz0 they showed no evidence of secondary structure (i.e. they 
exist as either extended chains or random coils). 
The results of the competition EIA with immobilized 
parental peptide and preincubation of eight sera with 
either parental or mutant peptide are given in Fig. 2. 
Preincubation with the parental peptide decreased the 
reactivity with the immobilized peptide more than pre- 
incubation with the mutant peptide. Three sera that 
showed some reactivity with the mutant peptide were 
similarly preincubated and subsequently tested against 
immobilized mutant peptide. Also in these cases, prein- 
cubation with the parental peptide decreased the reac- 
tivity more than preincubation with the mutant peptide. 
Preincubation with the control peptide, HIV-env 735- 
752. did not decrease the reactivity of the sera with 
either immobilized parental or mutant peptide (data not 
shown). 
3.2. Structural 
The circular dichroism spectra show that the parental 
Antlgenlc effects of threonlne at position 589 
2.5. Nucleur mugnetic resonance 
Resonance assignments were achieved usmg HOHAHAiTOCSY 
[15] and ROESY (rotating frame NOESY) spectra. The mixmg times 
for the HOHAHAlTOCSY spectra were 60 ms and 120 ms for the 
ROESY experiment. Distance restraints were obtained from NOESY 
spectra run at 53°C with a mixing time of 150 ms. The peptide samples 
were made up in the same solvents as for the CD experiments (but 
using d,-TFE) at a concentration of 5 mmol drn-‘. The presence of 
sequential NH-NH NOE cross peaks [17] from Ala-585 to Gln-597 in 
both peptides in TFE/H,O provided additional data to suggest that 
the peptides have significant and mdistinguishable a-helical contents 
in the TFE/H?O mixture. 
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2.6. Energy mirumkat~on 
Computations were carried out using the QUANTAKHARMM 
program package (Polygen Corp.. Waltham. MA). Structures were 
calculated for the peptides both in vacuum and immersed m a box of 
500 simulated water molecules [18]. The final low energy structures 
were obtained by energy minimization calculations which included all 
of the available distance restraints from the NOESY data. 
583 T 583 T 583 T 
a b c 
Fig. 1. The reactivity of human sera with the parental peptide HIV-env 
583-599 and the 589 threonine mutant peptide (abbreviated 583 and 
T, respectively, on the abscissa). The normahzed absorbance differ- 
ence between peptide-coated wells and those without peptide are ex- 
pressed on the ordinate: (a) 11 HIV-l-positive sera strongly reacted 
with HIV-env 5833599, (b) 31 HIV-l-positive sera with weak or no 
reactivity to HIV-env 583-599. and (c) 16 HIV-l-negative blood donor 
sera The pomts for each serum have been connected. 
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Competltlon EIA 
lmmoblltzed HIV-env 583-599 
Fig. 2. Competition enzyme immuno-assay with immobilized HIV-env 
5833599. The absorbance difference after preincubation of eight sera 
with peptides divided by their absorbance difference after preincuba- 
tion without peptide are given on the ordinate. The premcubation 
peptides and their concentrations are given on the abscissa. where 
583 = parental HIV-env 5833599 and T = threonine mutant peptide. 
The pomts for each serum have been connected 
(‘589A’) and mutant (‘589T’) peptides have indistin- 
guishable backbone conformations in a TFE/H,O mix- 
ture (Fig. 3). Additional CD spectra were obtained 
under a variety of solvent conditions. Under any given 
2oooo.n~ 
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250.0 
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Fig 3 Circular dichroism spectra of (a) ‘583’, LQARILAV- 
ERYLKDQQL at pH 2.9: and (b) ‘T’, LQARILTVERYLKDQQL 
at pH 2 8. The spectra were obtained at 2 1 “C in a 40% TFE/60% HZ0 
mixture. 
set of experimental conditions the two peptides always 
showed indistinguishable conformational behavior. 
For both peptides in TFE/HzO the 2D NOESY spec- 
tra (see Fig. 4) had intense sequential NH,-NH,,, cross 
peaks for all residues except those at the ends of the 
peptides. Also, the sequential C,H,-NH,,, cross peaks 
were quite weak. This cross-peak behavior is character- 
istic of peptides in a-helical conformations. Energy min- 
imization computations were carried out using the 
standard value of 2.55 A as sequential NH,-NH,,, dis- 
tance restraints. Fig. 5 shows a typical low-energy result 
obtained for the parental ‘589A’ peptide. A similar re- 
sult was obtained for the mutant ‘589T’ peptide. The 
corresponding energies of these structures were similar. 
The methyl group of the ‘589A’ sidechain is seen here 
to lie in the space between the side chains of ‘586R’ and 
‘593Y’. This space becomes more crowded when thre- 
onine is substituted at position 589. 
Interestingly, we observed that the positively charged 
side chains of ‘595K’ and ‘592R’ are predicted to form 
salt bridges with the negatively charged side chains of 
‘591E‘ and ‘596D’. respectively, when the simulations 
are carried out under vacuum conditions. However, in 
the presence of the simulated water molecules the dis- 
tances between those sidechain charges are over 7 A, 
which would obviate salt-bridge formation between the 
ith and (i + 4)th residues [19]. 
4. DISCUSSION 
By both CD spectropolarimetry and NMR spectros- 
copy we found that the parental and mutant HIV-env 
FZ 
k-w) 
7.5 
76 
7.7 
7.8 
7.9 
8.0 
8.1 
8.2 
8.3 
8.4 
8.5 
8.6 
8.7 
8.2 8.0 
Fl (ppm) 
Fig. 4. Two-dimensional NOESY spectrum of amide protons of 
LQARILAVERYLKDQQL at pH 2.9 in a 40% TFE1508 H:O/lO% 
‘HZO. The temperature was 5°C and the mixmg time was 150 ms. 
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Fig. Space filling model of LQARILAVERYLKDQQL obtained by energy minimization (see text). Several critical amino acid residues a 
labelled using the three letter abbreviation. 
Lre 
583-599 peptides have indistinguishable backbone con- 
formations and that they form a-helices in a 40% TFE/ 
60% HZ0 solvent mixture over a pH range from 2.5-9.0. 
The A to T mutation, in spite of markedly reducing the 
binding of human antibodies to the peptide, had no 
observable effect on the secondary structure of the pep- 
tide. Although the structure of the corresponding region 
in the entire native protein is, as yet, unknown, it can 
be argued that since the parental and mutant residues 
occur in identical contexts, similar secondary-structural 
tendencies of the peptides would correspond to second- 
ary-structural similarities between the mutant and pa- 
rental proteins in this region of gp41. Thus, the pre- 
dicted change [2,3] to a /3-structure in the mutant gp41 
may not occur. 
In contrast to HIV-env 583-599 the longer and anti- 
genitally stronger HIV-env 586-606 was largely disor- 
dered in alcohol/water solution as revealed by the CD 
spectra (Han et al., unpublished results), although it 
potentially could form the same salt bridges as are pos- 
sible for HIV-env 5833599. It cannot yet be settled 
whether it is the lack of residues 583-585 or the presence 
of residues 6OOG606 that disturbs the order. We note, 
however, that this is a counter example to the suggested 
rule that strongly antigenic peptides are more ordered 
than less antigenic ones [8]. 
Antibodies that react with peptides of this region do 
not neutralize the virus [I], and thus the antigenic effect 
on the peptide of the alanine to threonine mutation may 
be coincidental to the decrease in neutralization. Never- 
theless, the substitution may similarly abrogate the 
binding of hypothetically neutralizing antibodies to an 
overlapping composite epitope. 
Whether the escape mutation in gp41 abrogates the 
binding of neutralizing antibodies to the virus or inter- 
feres with their action in some other manner cannot be 
answered yet. Even if the region forms ol-helices in both 
parental and mutant forms of the proteins, as do the 
corresponding peptides, the mutation may still affect 
the conformation of the envelope glycoprotein complex: 
the larger side chain in the mutant may use space other- 
wise occupied by another region of the env-hetero-oli- 
gomer [20], e.g. in gp120. The affected neutralization 
epitope may be distant both in the primary structure 
and in three-dimensional space (see [21]). 
It is noteworthy in this context that glycine and serine 
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(both less bulky than threonine) can be substituted for 
alanine at position 589, without rendering the virus re- 
sistant to neutralization by human sera [l]. The three- 
dimensional structure shows that a bulkier residue 
might increase the free energy of the bound state by 
filling out a groove on the protein surface. An alterna- 
tive explanation would be that the free energy of the 
uncomplexed form is lower for the mutant than for the 
parental peptide. Either explanation could account for 
decreased binding of antibodies to the mutant peptide, 
to a hypothetical composite neutralization epitope, and 
of gp41 to the outer envelope glycoprotein gp120. This 
region of gp41 may contact gp120. as mutations both 
N- and C-terminal to it abrogate gp41-gpl20 associa- 
tion [22]. A decreased association of the envelope 
glycoproteins would also provide a testable explanation 
of the neutralization-insensitive phenotype; free gpl20 
can decrease the neutralization titre of human sera [23]. 
Whether this escape mutation is a general phenome- 
non and elicits antibodies in vivo, was addressed here 
by looking for antibodies in 42 sera that would preferen- 
tially recognize the mutant peptide. Hypothetically, the 
mutant but not the wild-type would bind antibodies that 
could block the binding or action of neutralizing anti- 
bodies. We conclude that no such evidence was found; 
all detectable antibodies were shown to have a higher 
affinity for the parental than for the mutant peptide. 
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